Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 17 | 2023 | 705 | 1.980 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 5 | 2018 | 56 | 1.040 |
Why?
|
| Macrophages | 12 | 2018 | 1004 | 0.880 |
Why?
|
| Viral Tropism | 5 | 2018 | 55 | 0.870 |
Why?
|
| CD4 Antigens | 11 | 2023 | 156 | 0.850 |
Why?
|
| HIV Envelope Protein gp120 | 9 | 2018 | 139 | 0.770 |
Why?
|
| HIV Infections | 9 | 2018 | 920 | 0.540 |
Why?
|
| Brain | 7 | 2018 | 1488 | 0.540 |
Why?
|
| Receptors, CCR5 | 6 | 2018 | 57 | 0.530 |
Why?
|
| AIDS Dementia Complex | 2 | 2006 | 12 | 0.510 |
Why?
|
| HIV Antibodies | 6 | 2018 | 141 | 0.500 |
Why?
|
| HIV-2 | 3 | 2013 | 23 | 0.490 |
Why?
|
| Viral Load | 2 | 2013 | 229 | 0.450 |
Why?
|
| Preservation, Biological | 1 | 2013 | 6 | 0.420 |
Why?
|
| Lymph Nodes | 4 | 2011 | 212 | 0.390 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 964 | 0.350 |
Why?
|
| Virus Internalization | 2 | 2009 | 97 | 0.350 |
Why?
|
| Virion | 3 | 2017 | 116 | 0.340 |
Why?
|
| Tropism | 2 | 2006 | 17 | 0.330 |
Why?
|
| HIV Fusion Inhibitors | 1 | 2008 | 9 | 0.300 |
Why?
|
| Semen | 1 | 2006 | 42 | 0.260 |
Why?
|
| Gene Products, env | 1 | 2004 | 21 | 0.230 |
Why?
|
| Genetic Variation | 1 | 2006 | 364 | 0.230 |
Why?
|
| Cell Line | 6 | 2023 | 2013 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 498 | 0.210 |
Why?
|
| Virus Cultivation | 2 | 2013 | 17 | 0.170 |
Why?
|
| Cells, Cultured | 3 | 2015 | 2099 | 0.150 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 97 | 0.140 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 137 | 0.140 |
Why?
|
| Antibodies, Neutralizing | 3 | 2018 | 191 | 0.140 |
Why?
|
| Neutralization Tests | 3 | 2018 | 125 | 0.130 |
Why?
|
| Humans | 17 | 2023 | 59471 | 0.120 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2005 | 63 | 0.110 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2005 | 79 | 0.110 |
Why?
|
| Receptors, HIV | 1 | 2012 | 17 | 0.100 |
Why?
|
| Virus Attachment | 1 | 2012 | 23 | 0.100 |
Why?
|
| Amino Acid Substitution | 3 | 2009 | 252 | 0.100 |
Why?
|
| HeLa Cells | 3 | 2010 | 526 | 0.100 |
Why?
|
| Amino Acid Sequence | 4 | 2010 | 1578 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2010 | 1975 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2010 | 171 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 2018 | 352 | 0.080 |
Why?
|
| Virus Replication | 2 | 2023 | 302 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 90 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2012 | 856 | 0.070 |
Why?
|
| Arginine | 1 | 2008 | 113 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2008 | 145 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2010 | 608 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2006 | 179 | 0.070 |
Why?
|
| CCR5 Receptor Antagonists | 1 | 2005 | 14 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 335 | 0.060 |
Why?
|
| Cell Fusion | 1 | 2004 | 45 | 0.060 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2004 | 22 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 48 | 0.060 |
Why?
|
| Protein Binding | 3 | 2018 | 1553 | 0.050 |
Why?
|
| Infant | 1 | 2008 | 1523 | 0.050 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2023 | 20 | 0.050 |
Why?
|
| HIV | 1 | 2003 | 69 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2006 | 1306 | 0.050 |
Why?
|
| Phenotype | 1 | 2004 | 1150 | 0.040 |
Why?
|
| Adult | 2 | 2008 | 15771 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 314 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 667 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2010 | 290 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2018 | 82 | 0.040 |
Why?
|
| Genes, env | 1 | 2017 | 15 | 0.040 |
Why?
|
| Phylogeny | 1 | 2018 | 332 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2023 | 844 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 82 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2018 | 167 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 177 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 638 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 452 | 0.030 |
Why?
|
| Animals | 3 | 2011 | 19649 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 807 | 0.030 |
Why?
|
| Immunization, Secondary | 1 | 2011 | 46 | 0.020 |
Why?
|
| Immunization | 1 | 2011 | 127 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 330 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 693 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 255 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 179 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 236 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 135 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 358 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 1141 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 252 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 448 | 0.020 |
Why?
|
| Male | 1 | 2006 | 27561 | 0.020 |
Why?
|
| Kidney | 1 | 2008 | 393 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 33 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 873 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 29 | 0.020 |
Why?
|
| Amides | 1 | 2005 | 51 | 0.020 |
Why?
|
| Female | 1 | 2006 | 30895 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 305 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 109 | 0.010 |
Why?
|
| Monocytes | 1 | 2005 | 345 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 375 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2003 | 32 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 273 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 439 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2003 | 247 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 236 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 768 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 2445 | 0.010 |
Why?
|